Clinical Trials Browser

Interventional × Cognitive Dysfunction × 90 days × Clear all

NCT06745583 2026-04-09

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Phase 2 Recruiting

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT06584110 2026-04-06

BUDPA

Phase NA Recruiting

Caregiver Burden, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT07510061 2026-04-03

ICARUS

Phase NA Recruiting

Hyperthermia, Skin Neoplasms, Heat Stress Disorders, Cognitive Dysfunction

NCT05896189 2026-04-02

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Phase NA Recruiting

Breast Neoplasms, Cognitive Dysfunction

NCT05860127 2026-03-23

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Phase NA Completed

133 enrolled 14 charts

Mixed Dementias, Dementia, Lymphoma, Follicular, Dementia, Vascular, Lewy Body Disease, Cognitive Dysfunction

NCT06662435 2026-03-23

GYNCOG

Phase NA Completed

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

NCT06664229 2026-03-20

Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

Phase NA Recruiting

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Phase 2 Completed

75 enrolled 47 charts

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

NCT04520139 2026-03-10

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Phase 1/2 Not yet recruiting

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Phase 3 Recruiting

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4 Active not recruiting

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT05894954 2026-02-18

EVANTHEA

Phase 3 Completed

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03536975 2026-02-17

CAREGIVERSPRO

Phase NA Completed

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05144516 2026-02-10

Cancer and Mild Cognitive Impairment Dyadic Intervention

Phase NA Recruiting

Psychological Well-Being, Communication, Neoplasms, Cognitive Dysfunction

NCT05637801 2026-02-05

Hope

Phase NA Active not recruiting

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06162026 2026-02-05

Cognitive Screening Made Easy for PCPs - R33 Phase

Phase NA Active not recruiting

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06928298 2026-02-05

Cognitive Screening Made Easy for PCPs - Administrative Supplement

Phase NA Recruiting

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06995443 2026-01-30

REGAIN

Phase NA Recruiting

Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT05230758 2026-01-22

Met Med Can

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction